Virtu Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,795
Closed -$1.36M 2094
2025
Q4
$1.36M Sell
26,795
-7,517
-22% -$384K 0.05% 245
2025
Q3
$1.9M Buy
+34,312
New +$2.01M 0.11% 177
2025
Q1
Sell
-90,751
Closed -$7.81M 1831
2024
Q4
$7.81M Buy
90,751
+56,822
+167% +$6.14M 0.41% 30
2024
Q3
$4.04M Buy
33,929
+13,949
+70% +$1.86M 0.22% 59
2024
Q2
$2.85M Buy
+19,980
New +$2.65M 0.2% 96
2024
Q1
Sell
-2,410
Closed -$249K 1883
2023
Q4
$249K Sell
2,410
-18,356
-88% -$1.82M 0.02% 697
2023
Q3
$1.89M Buy
+20,766
New +$1.83M 0.19% 96
2022
Q1
Sell
-7,936
Closed -$444K 1860
2021
Q4
$444K Buy
+7,936
New +$430K 0.05% 422
2021
Q1
Sell
-21,708
Closed -$758K 1892
2020
Q4
$758K Buy
+21,708
New +$750K 0.08% 307
2019
Q4
$267K Buy
9,230
+762
+9% +$21.1K 0.03% 756
2019
Q3
$219K Sell
8,468
-838
-9% -$21.2K 0.02% 919
2019
Q2
$237K Buy
+9,306
New +$230K 0.01% 933
2018
Q4
Sell
-14,658
Closed -$345K 1858
2018
Q3
$345K Sell
14,658
-19,218
-57% -$469K 0.02% 779
2018
Q2
$781K Buy
+33,876
New +$805K 0.05% 544
2017
Q2
Sell
-12,420
Closed -$213K 486
2017
Q1
$213K Buy
+12,420
New +$216K 0.02% 358
2016
Q1
Sell
-7,010
Closed -$204K 480
2015
Q4
$204K Buy
+7,010
New +$194K 0.03% 340
2013
Q3
Sell
-167,160
Closed -$2.59M 316
2013
Q2
$2.59M Buy
+167,160
New +$2.78M 0.25% 76

Other funds holding NVO

Virtu Financial's NVO Position: Q1 2026 in Review

Virtu Financial sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 26,795 shares — an estimated $1.36M sold.

Virtu Financial first reported a position in NVO in Q2 2013 and held it in 17 quarters. The position peaked at $7.81M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Virtu Financial reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 26,795 Novo Nordisk shares in Q1 2026, an estimated $1.36M.
  • Virtu Financial first reported a position in Novo Nordisk in Q2 2013 and held it in 17 quarters.
  • Virtu Financial's Novo Nordisk position peaked at $7.81M in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.